Top 10 Russell 2000 weekly gainers and losers as Wall Street crashes

Seeking Alpha News (Sat, 05-Apr 5:55 PM)

Wall Street on Friday suffered its biggest weekly retreat since the peak of the COVID-19 pandemic collapse in 2020. The panic was sparked by U.S. President Donald Trump's sweeping reciprocal tariffs announcement.

The Russell 2000 index (RTY), the barometer for small-cap stocks, slid -9.68% for the week to end in bear market territory. 

Here are the top 10 Russell 2000 losers of the week:

  1. Aldeyra Therapeutics (NASDAQ:ALDX); weekly decline -71.7%, Quant rating Hold.
  2. Open Lending (NASDAQ:LPRO); weekly decline -63.6%, Quant rating Strong Sell. 
  3. Vaxcyte (NASDAQ:PCVX); weekly decline -54.5%, Quant rating Hold. 
  4. Edgewise Therapeutics (NASDAQ:EWTX); weekly decline -50.5%, Quant rating Hold. 
  5. Lexeo Therapeutics (NASDAQ:LXEO); weekly decline -43.1%, Quant rating Strong Sell.
  6. Metsera (NASDAQ:MTSR); weekly decline -40%, not rated by Quant.
  7. Neurogene (NASDAQ:NGNE); weekly decline -39.5%, Quant rating Strong Sell. 
  8. RxSight (NASDAQ:RXST); weekly decline -38.8%, Quant rating Hold.
  9. Orchestra BioMed (NASDAQ:OBIO); weekly decline -37.3%, Quant rating Hold.
  10. Taysha Gene Therapies (NASDAQ:TSHA); weekly decline -36.8%, Quant rating Hold.            

And here are the top 10 Russell 2000 gainers of the week:

  1. Alumis (NASDAQ:ALMS); weekly advance +78.2%, not rated by Quant.
  2. Corcept Therapeutics (NASDAQ:CORT); weekly advance +36.3%, Quant rating Hold.
  3. Maiden (NASDAQ:MHLD); weekly advance +29.6%, not rated by Quant.
  4. Mr. Cooper (NASDAQ:COOP); weekly advance +28.4%, Quant rating Hold. 
  5. Verrica Pharmaceuticals (NASDAQ:VRCA); weekly advance +22.4%, Quant rating Hold.
  6. HomeStreet (NASDAQ:HMST); weekly advance +22%, Quant rating Hold.
  7. Bluebird Bio (NASDAQ:BLUE); weekly advance +21.3%, Quant rating Hold.
  8. Roadzen (NASDAQ:RDZN); weekly advance +19.1%, Quant rating Strong Sell.
  9. Sunrun (NASDAQ:RUN); weekly advance +17.7%, Quant rating Strong Sell. 
  10. CervoMed (NASDAQ:CRVO); weekly advance +16.9%, Quant rating Hold.            

For reference, Seeking Alpha's Quant system consistently outperforms the S&P (SP500), driven by powerful computer processing and SA's special 'Quantamental' analysis. It awards grades to stocks based on collective value, growth, profitability, earnings per share revisions, and price momentum metrics.

Here are some exchange-traded funds that track small-cap stocks: (NYSEARCA:IJR), (NYSEARCA:IWM), (NYSEARCA:VB), (NYSEARCA:VBR), (NYSEARCA:VBK), (NYSEARCA:SCHA), (NYSEARCA:SPSM), and (NYSEARCA:DFAS).